Cyteir Therapeutics Inc (CYT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 100,600 | 72,800 | 32,100 | 121,300 | 91,400 |
| Depreciation Amortization | 73,200 | 48,300 | 24,300 | 95,100 | 70,000 |
| Income taxes - deferred | 24,900 | 20,900 | 5,900 | 24,300 | 0 |
| Accounts receivable | -51,700 | -39,100 | -13,100 | -8,700 | 0 |
| Accounts payable and accrued liabilities | 16,000 | -2,700 | -10,500 | 19,900 | 0 |
| Other Working Capital | -103,900 | -79,900 | -52,700 | -36,800 | -43,100 |
| Other Operating Activity | 23,600 | 29,400 | 17,900 | -15,900 | 11,900 |
| Operating Cash Flow | $82,700 | $49,700 | $3,900 | $199,200 | $130,200 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -54,300 | -32,600 | -15,700 | -77,400 | -54,400 |
| Net Acquisitions | -100 | N/A | N/A | -69,800 | -32,300 |
| Other Investing Activity | 73,000 | 9,900 | 1,300 | 6,800 | 9,400 |
| Investing Cash Flow | $18,600 | $-22,700 | $-14,400 | $-140,400 | $-77,300 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 100 | N/A | -10,300 | 0 |
| Debt Issued | -53,900 | 3,000 | 13,300 | 3,000 | 0 |
| Common Stock Issued | 4,600 | 3,600 | 2,700 | 2,300 | 0 |
| Common Stock Repurchased | -51,300 | -37,500 | -13,800 | -42,500 | 0 |
| Other Financing Activity | 0 | 0 | 0 | 0 | -40,100 |
| Financing Cash Flow | $-100,600 | $-30,800 | $2,200 | $-47,500 | $-40,100 |
| Exchange Rate Effect | -2,200 | -800 | -200 | -1,000 | -400 |
| Beginning Cash Position | 12,000 | 12,000 | 12,000 | 1,700 | 1,700 |
| End Cash Position | 10,500 | 7,400 | 3,500 | 12,000 | 14,100 |
| Net Cash Flow | $-1,500 | $-4,600 | $-8,500 | $10,300 | $12,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 82,700 | 49,700 | 3,900 | 199,200 | 130,200 |
| Capital Expenditure | -54,300 | -32,600 | -15,700 | -77,400 | 0 |
| Free Cash Flow | 28,400 | 17,100 | -11,800 | 121,800 | 130,200 |